Prostate cancer is one of the most common malignancies in men globally. Hormonal therapies targeting the androgen–androgen ...

We read with great interest the published results of the RADIOSA trial by Giulia Marvaso and colleagues.1 This well designed ...

A highly expensive, revolutionary treatment for recurrent prostate cancer is for the first time in Australia available at a ...

(UroToday.com) The 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting held in New Orleans, LA, was host to a Radiopharmaceutical Therapy Trials with Dosimetry session. Dr.

(UroToday.com) The Interdisciplinary Genitourinary Cancer Forum 2025, held in St. Petersburg, Florida, United States, was host to the Prostate Cancer Session 2: Local Treatments. Dr. Peter Carroll ...

Mogensen AW et al. The Use of PSMA PET/CT Improves Overall Survival in Men with Biochemically Recurrent Prostate Cancer ...

The study involved 182 patients with recurrent prostate cancer, showing high metastasis detection rates, especially after radiation therapy or surgery followed by salvage radiation. Findings challenge ...

A feasibility study for salvage radiation therapy in prostate cancer. Story by Science X staff • 11mo. A n editorial paper was published in Oncoscience on May 20, 2024, titled, ...

References: Ekanger C, Helle SI, Reisæter L, et al. Salvage reirradiation for locally recurrent prostate cancer: Results from a prospective study with 7.2 years of follow-up. J Clin Oncol ...

Chang JH, Park W, Park JS, et al. Significant of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery. Int J Urol . 2015;22 ...

Delaying salvage radiation therapy after radical prostatectomy for men with just one high-risk factor for prostate cancer recurrence may significantly increase risk for all-cause mortality, a ...